+ epigenetic regulation of drug metabolism amber frick, pharmd november 19, 2013...
TRANSCRIPT
![Page 2: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/2.jpg)
+Pharmacogenomics
![Page 3: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/3.jpg)
+Pharmacogenomics Case
You prescribed simvastatin 80 mg daily to a patient with hyperlipidemia. They return to your office with extreme muscle aches, and you suspect rhabdomyolysis. Why is the patient experiencing these side effects? What genetic and/or environmental factors may be involved? What tests should you perform? What actions should you take next? If you were designing a clinical trial for a new statin medication, what
would you include in the experimental design?
![Page 4: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/4.jpg)
+SLCO1B1 Association with Myopathy
SEARCH Collaborative Group. N Engl J Med 2008;359
SLCO1B1
Estimated Cumulative Risk of Myopathy
![Page 5: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/5.jpg)
+Epigenetics TEDx and RadioLab
![Page 6: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/6.jpg)
+Epigenetics
Changes in gene activity caused by mechanisms other than changes in underlying DNA sequence
Patterns vary between gender, age groups, species, tissue, and cells
Involves a network of layered processes: DNA methylation Histone modification Non-protein coding (nc) RNAs
![Page 7: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/7.jpg)
+Epigenetic Mechanisms Affect Health
![Page 8: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/8.jpg)
+Epigenetic Mechanisms Affect Drug Response
Kacevska M, et al. Pharmacogenomics 2012;13.
![Page 9: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/9.jpg)
+Epigenetic Machinery
Ivanov M, et al. Clinical Pharmacology and Therapeutics 2012;92.
![Page 10: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/10.jpg)
+DNA Methylation
![Page 11: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/11.jpg)
+Fifth Base of the Genome
DNMT1
Read A, and Donnai D. New Clinical Genetics. Bloxham UK: Scion Publishing Ltd, 2007.
![Page 12: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/12.jpg)
+Sixth Base of the Genome
Branco MR, et al. Nature Reviews Genetics 2012;13.
![Page 13: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/13.jpg)
+Aberrant DNA Methylation in Cancer
Wright J. Nature 2013;498.
![Page 14: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/14.jpg)
+Aberrant DNA Methylation in Cancer
Ivanov M, et al. Clinical Pharmacology and Therapeutics 2012;92.
![Page 15: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/15.jpg)
+On-Off Switch for Genes
Ingelman-Sundberg M, et al. Drug Metabolism and Disposition 2013;41.
![Page 16: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/16.jpg)
+Epigenetic Regulation of ADME Genes
Ivanov M, et al. Clinical Pharmacology and Therapeutics 2012;92.
![Page 17: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/17.jpg)
+Clinical Relevance of Methylation
GSTP1 methylation and DNA methyltransferase inhibitor treatment of prostate cancer and doxorubicin treatment of breast cancer
UGT1A1 and irinotecan treatment of colon cancer
SLC19A1 and methotrexate treatment of lymphomas
GPx3 and cisplatin treatment of head and neck cancer
VDR and calcitriol treatment of breast cancer
![Page 18: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/18.jpg)
+Methylation of GSTP1
Rønneberg JA, et al. Cancer Res 2008;68.
![Page 19: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/19.jpg)
+DNMT Inhibitors
Azacitadine Decitadine
![Page 20: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/20.jpg)
+Histone Modification
Arrowsmith CH, et al. Nature Reviews 2012;11.
![Page 21: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/21.jpg)
+Histone Modification
![Page 22: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/22.jpg)
+HDAC and CYP3A4
Wu Y, et al. Journal of Pharmaceutical and Biomedical Analysis 2012;58.
![Page 23: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/23.jpg)
+HDAC Inhibitors
Vorinostat
Romidepsin
Arrowsmith CH, et al. Nature Reviews 2012;11.
![Page 24: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/24.jpg)
+Non-protein coding RNAs
Only 2% of the genome encodes protein-coding genes via mRNA transcripts
miRNAs are the most widely studied Approximately 22 nucleotides in length Mediate post-transcriptional gene silencing Regulate the translation of >60% of protein-coding
genes
lncRNA targets histone-modifying enzymes to specific genomic loci
DNA methylation and histone modification control miRNA levels
![Page 25: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/25.jpg)
+miRNAs and Drug Metabolism
Kacevska M, et al. Pharmacogenomics 2012;13.
![Page 26: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/26.jpg)
+miRNAs and Drug Sensitivity
Kacevska M, et al. Pharmacogenomics 2012;13.
![Page 27: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/27.jpg)
+Pleiotropic Effects of Non-Epigenetic Drugs
Lotsch J. Trends in Molecular Medicine 2013.
![Page 28: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/28.jpg)
+Pleiotropic Effects of Non-Epigenetic Drugs
Lotsch J. Trends in Molecular Medicine 2013.
![Page 29: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/29.jpg)
+Specificity of Epigenetic Agents
Dawson MA, Kouzarides. Cell 2012;150.
EPZ004777*IC50 pM Range
*
Arrowsmith CH, et al. Nature Reviews 2012;11.
![Page 30: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/30.jpg)
+Specificity of Epigenetic Agents
Compound 6J *IC50 1 μM
*
Arrowsmith CH, et al. Nature Reviews 2012;11.
![Page 31: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/31.jpg)
+Specificity of Epigenetic Agents
![Page 32: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/32.jpg)
+Epigenetic Targets
Dawson MA, Kouzarides. Cell 2012;150.
![Page 33: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/33.jpg)
+Full Drug Pipeline
![Page 34: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/34.jpg)
+Pharmacoepigenetics Case 1
CYP2W1 is polymorphic with two major allelic variants (*2 and *6). You find hypomethylation in a set of colon cancer samples. Currently, the chemotherapeutic regimens used to treat colon cancer are not tolerated well with numerous non-specific side effects. As a drug developer, what therapeutic intervention would you design? What potential issues may arise in terms of drug-drug interactions?
Gomez A, Ingelman-Sundberg M. Clinical Pharmacology & Therapeutics 2009; 85.
![Page 35: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/35.jpg)
+Pharmacoepigenetics Case 2
Colorectal cancer cells can be made more sensitive to the effects of 5-fluorouracil with the use of lovastatin via an epigenetic mechanism. What epigenetic mechanism occurs with the administration of
lovastatin? How would therapy be affected by the co-administration of
epigenetics targeting therapies? How would response be affected by capecitabine administration
rather than 5-fluorouracil?
![Page 36: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/36.jpg)
+Pharmacoepigenetics Case 3
The HDAC and DNMT inhibitors are given to the patient as long as they benefit from treatment. Given that current epigenetic reversing drugs are highly promiscuous in their drug targets: What are the likely long-term consequences of epigenetic
therapeutic regulation? How does administration affect expression of drug metabolizing
enzymes? What drug-drug interactions are of concern?
![Page 37: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/37.jpg)
+Pharmacoepigenetics Case 3
The HDAC and DNMT inhibitors are given to the patient as long as they benefit from treatment. Given that current epigenetic reversing drugs are highly promiscuous in their drug targets: What are the likely long-term consequences of epigenetic
therapeutic regulation? How does administration affect expression of drug metabolizing
enzymes? What drug-drug interactions are of concern?
![Page 38: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/38.jpg)
+Pharmacoepigenetics Case 4
miRNA therapeutics are gaining momentum. For instance, miR-122 (Miravirsin) is being investigated in hepatitis C and hepatocellular carcinoma. Would you use miRNA-based therapy to regulate drug
sensitivity or modulate drug metabolizing enzymes, drug transporters, and nuclear receptors?
What hurdles must you overcome to develop miRNA-based therapy?
![Page 39: + Epigenetic Regulation of Drug Metabolism Amber Frick, PharmD November 19, 2013 adfrick@email.unc.edu](https://reader031.vdocuments.mx/reader031/viewer/2022032607/56649ec95503460f94bd6a37/html5/thumbnails/39.jpg)
+Questions, Comments, Suggestions, or Constructive Criticism?